Clinical Trial Update: Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin [Phase 2]

View source ↗

Summary

The document notes completion of a Phase 2 pilot trial evaluating the effect of aprepitant on aldosterone secretion in patients with type 2 diabetes mellitus an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Type 2 Diabetes, Hypertension | Phase 2 | Status: COMPLETED